KR20010071777A - Ｇａｂａ 유사체 및 카페인을 포함하는 조성물 - Google Patents

Ｇａｂａ 유사체 및 카페인을 포함하는 조성물 Download PDF

Info

Publication number
KR20010071777A
KR20010071777A KR1020017000260A KR20017000260A KR20010071777A KR 20010071777 A KR20010071777 A KR 20010071777A KR 1020017000260 A KR1020017000260 A KR 1020017000260A KR 20017000260 A KR20017000260 A KR 20017000260A KR 20010071777 A KR20010071777 A KR 20010071777A
Authority
KR
South Korea
Prior art keywords
caffeine
formula
composition
compound
gabapentin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020017000260A
Other languages
English (en)
Korean (ko)
Inventor
레슬리 매그너스
캐서린 에이. 시갈
Original Assignee
로즈 암스트롱, 크리스틴 에이. 트러트웨인
워너-램버트 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로즈 암스트롱, 크리스틴 에이. 트러트웨인, 워너-램버트 캄파니 filed Critical 로즈 암스트롱, 크리스틴 에이. 트러트웨인
Publication of KR20010071777A publication Critical patent/KR20010071777A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020017000260A 1998-07-09 1999-06-18 Ｇａｂａ 유사체 및 카페인을 포함하는 조성물 Ceased KR20010071777A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
US60/092,131 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (1)

Publication Number Publication Date
KR20010071777A true KR20010071777A (ko) 2001-07-31

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017000260A Ceased KR20010071777A (ko) 1998-07-09 1999-06-18 Ｇａｂａ 유사체 및 카페인을 포함하는 조성물

Country Status (13)

Country Link
US (1) US6326374B1 (https=)
EP (1) EP1094817A1 (https=)
JP (1) JP2002520286A (https=)
KR (1) KR20010071777A (https=)
AU (1) AU772156B2 (https=)
BR (1) BR9911917A (https=)
CA (1) CA2332915C (https=)
ID (1) ID28277A (https=)
NO (1) NO20010119D0 (https=)
NZ (1) NZ508490A (https=)
PL (1) PL345340A1 (https=)
WO (1) WO2000002562A1 (https=)
ZA (1) ZA200007168B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126999A (en) 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
DE60022333T2 (de) 1999-04-09 2006-07-06 Euro-Celtique S.A. Natrium kanalblocker zusammensetzungen und deren verwendung
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
IL160523A0 (en) 2001-09-03 2004-07-25 Newron Pharm Spa PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
RU2335342C2 (ru) * 2004-03-12 2008-10-10 Уорнер-Ламберт Компани Ллс C1-симметричные бисфосфиновые лиганды и их применение в асимметрическом синтезе прегабалина
EP1735324B1 (en) * 2004-04-01 2008-08-20 Warner-Lambert Company LLC Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
MXPA06014228A (es) * 2004-06-21 2007-02-14 Warner Lambert Co Preparacion de pregabalina y compuestos relacionados.
ATE471147T1 (de) * 2004-09-10 2010-07-15 Newron Pharm Spa Verwendung von (r)-(halogenbenzyloxy)-benzylamino-propanamiden als natrium- und/oder calciumkanal- selektive modulatoren
EP1963280B1 (en) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
WO2009021058A2 (en) 2007-08-06 2009-02-12 Trinity Labortories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
JP2010043063A (ja) * 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) * 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
AU7604194A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
US5443838A (en) 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
HU224720B1 (en) 1996-03-14 2006-01-30 Warner Lambert Co Novel substituted cyclic amino acid derivatives use as pharmaceutical agents
CA2264182A1 (en) 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
ATE361909T1 (de) * 1996-10-23 2007-06-15 Warner Lambert Co Substituierte gamma-aminobuttersäurederivate als arzneimittel
WO1999012537A1 (en) * 1997-09-08 1999-03-18 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
NO20010119L (no) 2001-01-08
ZA200007168B (en) 2002-03-04
CA2332915C (en) 2006-10-24
JP2002520286A (ja) 2002-07-09
AU772156B2 (en) 2004-04-08
PL345340A1 (en) 2001-12-17
EP1094817A1 (en) 2001-05-02
US6326374B1 (en) 2001-12-04
WO2000002562A1 (en) 2000-01-20
AU4691099A (en) 2000-02-01
ID28277A (id) 2001-05-10
NO20010119D0 (no) 2001-01-08
NZ508490A (en) 2003-08-29
BR9911917A (pt) 2001-03-27
CA2332915A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
CA2333024C (en) Method for the treatment of insomnia
KR20010071777A (ko) Ｇａｂａ 유사체 및 카페인을 포함하는 조성물
US20090137565A1 (en) Method for treatment of movement disorders
US6680343B1 (en) Treatment of renal colic with GABA analogs
US20040002543A1 (en) Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain
KR20010071776A (ko) 대상포진의 치료를 위한 ｇａｂａ 유사체 및항바이러스제를 포함하는 제약 조성물
AU758103B2 (en) Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain
KR20010108466A (ko) 우울증 치료용 ｇａｂａ 유사체와 삼환계 화합물의 복합제제
MXPA00011648A (es) Composiciones que comprenden analogos gaba y cafeina
EP1094804B1 (en) The treatment of renal colic with gaba analogs
US20030045500A1 (en) Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
MXPA00011647A (en) The treatment of renal colic with gaba analogs
KR20080100284A (ko) 비-회복성 수면을 위한 알파-2-델타 리간드
MXPA00011509A (en) Method for the treatment of insomnia
MXPA00011507A (en) Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010108

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040618

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060224

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060712

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20060224

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20061012

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20060712

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20070111

Appeal identifier: 2006101009082

Request date: 20061012

J801 Dismissal of trial

Free format text: REJECTION OF TRIAL FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20061012

Effective date: 20070111

PJ0801 Rejection of trial

Patent event date: 20070111

Patent event code: PJ08011S01D

Comment text: Decision on Dismissal of Request for Trial (Dismissal of Decision)

Decision date: 20070111

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2006101009082

Request date: 20061012